530163 logo

Kerala Ayurveda Limited Stock Price

BSE:530163 Community·₹5.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

530163 Share Price Performance

₹464.95
188.10 (67.94%)
₹464.95
188.10 (67.94%)
Price ₹464.95

530163 Community Narratives

There are no narratives available yet.

Recent 530163 News & Updates

Kerala Ayurveda Limited Key Details

₹1.3b

Revenue

₹236.5m

Cost of Revenue

₹1.1b

Gross Profit

₹1.2b

Other Expenses

-₹130.3m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-10.83
Gross Margin
82.15%
Net Profit Margin
-9.83%
Debt/Equity Ratio
548.2%

Kerala Ayurveda Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards

About 530163

Founded
1945
Employees
367
CEO
Vivek Sunder
WebsiteView website
www.keralaayurveda.biz

Kerala Ayurveda Limited manufactures and sells ayurvedic products in India. It offers classical and proprietary ayurvedic medicines, including therapeutic formulations, as well as health supplements, skin and beauty care products, and specialty foods. The company’s products include pain relief, joint and muscle care, women and men health, immunity and general wellness, stress management and brain health, skin, hair and personal care, metabolism and gut health, child care and teen health, and geriatric care. It provides wellness centers and clinics, hospitals, health village, wellness resort, and yoga therapy services, as well as academies. The company was founded in 1945 and is headquartered in Aluva, India. Kerala Ayurveda Limited operates as a subsidiary of Katra Holdings Limited.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Indian Market Performance

  • 7 Days: 1.5%
  • 3 Months: -1.7%
  • 1 Year: -4.7%
  • Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. In contrast, the market has seen a decline of 4.7% over the last 12 months. Looking forward, earnings are forecast to grow by 16% annually. Market details ›